AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Sulta Cell: Safety, Efficacy, and Ongoing Studies
This chapter provides an overview of Sulta Cell, a cell-based gene therapy for multiple myeloma that has been approved by the FDA. It discusses the Cartitude 1 phase 1B2 study, baseline characteristics of patients, adverse events, cytokine release syndrome, and neurotoxicity. The chapter also mentions ongoing studies with Sulta Cell and its high activity in relapsed refractory disease.